373858836	373858836	CD	B-NP	O
|	|	NN	I-NP	O
LRH	LRH	NN	I-NP	O
|	|	NN	I-NP	O
60323109	60323109	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
3186943	3186943	CD	B-NP	O
|	|	CC	I-NP	O
11/16/2007	11/16/2007	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
INCACERATED	INCACERATED	NNP	I-NP	O
HERNIA	HERNIA	NNP	I-NP	O
,	,	,	O	O
SEPSIS	SEPSIS	NNP	B-NP	O
,	,	,	O	O
|	|	NNP	B-NP	O
Unsigned	Unsigned	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
8/28/2007	8/28/2007	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Unsigned	Unsigned	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
2/26/2007	2/26/2007	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
CELLAR	CELLAR	NN	B-NP	O
,	,	,	O	O
DONN	DONN	NNP	B-NP	O
WILL	WILL	NNP	I-NP	O
M.D.	M.D.	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Include	Include	VBP	B-VP	O
Tylenol	Tylenol	NN	B-NP	O
325	325	CD	I-NP	O
to	to	TO	I-NP	O
650	650	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.	q.	NN	I-NP	O
4	4	CD	I-NP	O
h.	h.	NN	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
DuoNeb	DuoNeb	NNP	B-NP	O
3/0	3/0	CD	I-NP	O
.5	.5	CD	I-NP	O
mg	mg	NN	I-NP	O
q.	q.	NN	I-NP	O
6	6	CD	I-NP	O
h.	h.	NN	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
,	,	,	O	O
amiodarone	amiodarone	NN	B-NP	O
400	400	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
for	for	IN	B-PP	O
six	six	CD	B-NP	O
more	more	JJR	I-NP	O
days	day	NNS	I-NP	O
and	and	CC	O	O
then	then	RB	B-ADVP	O
400	400	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
hold	hold	VBP	B-VP	O
for	for	IN	B-PP	O
systolic	systolic	JJ	B-NP	O
less	less	JJR	I-NP	O
than	than	IN	B-PP	O
90	90	CD	B-NP	O
,	,	,	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
55	55	CD	B-NP	O
,	,	,	O	O
econazole	econazole	NN	B-NP	O
nitrate	nitrate	NN	I-NP	O
topical	topical	JJ	I-NP	O
daily	daily	NN	I-NP	O
,	,	,	O	O
heparin	heparin	NN	B-NP	B-protein
5000	5000	CD	B-NP	I-protein
units	unit	NNS	I-NP	I-protein
subcutaneously	subcutaneously	RB	B-ADVP	O
q.	q.	VBP	B-VP	O
12	12	CD	B-NP	O
h.	h.	NN	I-NP	O
,	,	,	O	O
Regular	Regular	JJ	B-NP	B-protein
Insulin	Insulin	NN	I-NP	I-protein
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
subcutaneously	subcutaneously	RB	B-NP	O
q.	q.	RB	I-NP	O
6	6	CD	I-NP	O
h.	h.	NN	I-NP	O
,	,	,	O	O
Imodium	Imodium	NN	B-NP	O
A-D	A-D	NN	I-NP	O
2	2	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
metoclopramide	metoclopramide	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.i.d.	q.i.d.	FW	I-ADVP	O
,	,	,	O	O
Lopressor	Lopressor	NN	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.	q.	NN	I-NP	O
6	6	CD	I-NP	O
h.	h.	NN	I-NP	O
,	,	,	O	O
hold	hold	VBP	B-VP	O
for	for	IN	B-PP	O
systolic	systolic	JJ	B-NP	O
less	less	JJR	I-NP	O
than	than	IN	B-PP	O
90	90	CD	B-NP	O
,	,	,	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
55	55	CD	B-NP	O
,	,	,	O	O
omeprazole	omeprazole	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
oxycodone	oxycodone	NN	B-NP	O
1	1	CD	I-NP	O
mg	mg	NN	I-NP	O
per	per	IN	B-PP	O
1	1	CD	B-NP	O
mL	mL	NN	I-NP	O
solution	solution	NN	I-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
total	total	NN	I-NP	O
of	of	IN	B-PP	O
5	5	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.	q.	NN	I-NP	O
4	4	CD	I-NP	O
h.	h.	NN	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
Carafate	Carafate	NN	B-NP	O
1	1	CD	I-NP	O
gm	gm	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.i.d.	q.i.d.	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
Ambien	Ambien	IN	B-ADVP	O
2.5	2.5	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
nightly	nightly	RB	I-ADVP	O
.	.	.	O	O

DIET	DIET	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
currently	currently	RB	B-ADVP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
house	house	NN	I-NP	O
diet	diet	NN	I-NP	O
.	.	.	O	O

TPN	TPN	NN	B-NP	B-protein
was	be	VBD	B-VP	O
d/c	d/c	NN	B-NP	O
`	`	``	O	O
ed	ed	VBN	B-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

ACTIVITY	ACTIVITY	NN	B-NP	O
:	:	:	O	O
He	He	PRP	B-NP	O
may	may	MD	B-VP	O
walk	walk	VB	I-VP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-VP	O
.	.	.	O	O

ADMISSION	ADMISSION	NN	B-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
Incarcerated	Incarcerate	VBN	B-VP	O
chronic	chronic	JJ	B-NP	O
ventral	ventral	JJ	I-NP	O
hernia	hernia	NN	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
sigmoid	sigmoid	JJ	I-NP	O
colectomy	colectomy	NN	I-NP	O
,	,	,	O	O
colostomy	colostomy	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
Hartmann	Hartmann	NNP	B-NP	O
's	's	POS	B-NP	O
operation	operation	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
to	to	TO	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Galla	Galla	NNP	I-NP	O
in	in	IN	B-PP	O
two	two	CD	B-NP	O
weeks	week	NNS	I-NP	O
and	and	CC	O	O
Dr.	Dr.	NNP	B-NP	O
Caracciolo	Caracciolo	NNP	I-NP	O
who	who	WP	B-NP	O
is	be	VBZ	B-VP	O
the	the	DT	B-NP	O
attending	attend	VBG	I-NP	O
in	in	IN	B-PP	O
two	two	CD	B-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
should	should	MD	B-VP	O
also	also	RB	I-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Smutzler	Smutzler	NNP	I-NP	O
,	,	,	O	O
cardiology	cardiology	NN	B-NP	O
in	in	IN	B-PP	O
2	2	CD	B-NP	O
months	month	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
Dr.	Dr.	NNP	B-NP	O
Parramore	Parramore	NNP	I-NP	O
,	,	,	O	O
GI	GI	NNP	B-NP	O
in	in	IN	B-PP	O
2-4	2-4	CD	B-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
72-year-old	72-year-old	JJ	I-NP	O
male	male	JJ	I-NP	O
admitted	admit	VBN	B-VP	O
for	for	IN	B-PP	O
an	an	DT	B-NP	O
incarcerated	incarcerate	VBN	I-NP	O
chronic	chronic	JJ	I-NP	O
ventral	ventral	JJ	I-NP	O
hernia	hernia	NN	I-NP	O
,	,	,	O	O
postoperative	postoperative	JJ	B-NP	O
day	day	NN	I-NP	O
6	6	CD	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
sigmoid	sigmoid	JJ	I-NP	O
colectomy	colectomy	NN	I-NP	O
,	,	,	O	O
colostomy	colostomy	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
Hartmann	Hartmann	NNP	B-NP	O
's	's	POS	B-NP	O
operation	operation	NN	I-NP	O
.	.	.	O	O

Hospital	Hospital	NN	B-NP	O
course	course	NN	I-NP	O
was	be	VBD	B-VP	O
complicated	complicate	VBN	I-VP	O
by	by	IN	B-PP	O
postoperative	postoperative	JJ	B-NP	O
acute	acute	JJ	I-NP	O
respiratory	respiratory	JJ	I-NP	O
failure	failure	NN	I-NP	O
,	,	,	O	O
respiratory	respiratory	JJ	B-NP	O
acidosis	acidosis	NN	I-NP	O
with	with	IN	B-PP	O
metabolic	metabolic	JJ	B-NP	O
acidosis	acidosis	NN	I-NP	O
,	,	,	O	O
pleural	pleural	JJ	B-NP	O
effusion	effusion	NN	I-NP	O
,	,	,	O	O
hypokalemia	hypokalemia	NN	B-NP	O
,	,	,	O	O
myocardial	myocardial	JJ	B-NP	O
infarction	infarction	NN	I-NP	O
,	,	,	O	O
thrombocytopenia	thrombocytopenia	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
delirium	delirium	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
known	known	JJ	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
penile	penile	JJ	B-NP	O
cancer	cancer	NN	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
penectomy	penectomy	NN	I-NP	O
complicated	complicate	VBN	B-VP	O
by	by	IN	B-PP	O
perineal	perineal	JJ	B-NP	O
urethrocutaneous	urethrocutaneous	JJ	I-NP	O
fistula	fistula	NN	I-NP	O
,	,	,	O	O
chronic	chronic	JJ	B-NP	O
anemia	anemia	NN	I-NP	O
requiring	require	VBG	B-VP	O
transfusions	transfusion	NNS	B-NP	O
,	,	,	O	O
non-insulin-dependant	non-insulin-dependant	JJ	B-NP	O
diabetes	diabete	NNS	I-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
hypercholesterolemia	hypercholesterolemia	NN	B-NP	O
,	,	,	O	O
obesity	obesity	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
recurrent	recurrent	JJ	B-NP	O
UTIs	UTI	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
suprapubic	suprapubic	JJ	I-NP	O
catheter	catheter	NN	I-NP	O
placed	place	VBN	B-VP	O
by	by	IN	B-PP	O
Urology	Urology	NNP	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
postoperative	postoperative	JJ	I-NP	O
course	course	NN	I-NP	O
otherwise	otherwise	RB	B-ADVP	O
was	be	VBD	B-VP	O
alright	alright	RB	B-ADVP	O
.	.	.	O	O

He	He	PRP	B-NP	O
started	start	VBD	B-VP	O
having	have	VBG	I-VP	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
on	on	IN	B-PP	O
7/28/07	7/28/07	CD	B-NP	O
,	,	,	O	O
initially	initially	RB	B-ADVP	O
remained	remain	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
with	with	IN	B-PP	O
normal	normal	JJ	B-NP	O
blood	blood	NN	I-NP	O
pressures	pressure	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
floor	floor	NN	I-NP	O
on	on	IN	B-PP	O
7/28/07	7/28/07	CD	B-NP	O
,	,	,	O	O
wherein	wherein	IN	B-SBAR	O
he	he	PRP	B-NP	O
developed	develop	VBD	B-VP	O
rapid	rapid	JJ	B-NP	O
ventricular	ventricular	JJ	I-NP	O
response	response	NN	I-NP	O
to	to	TO	B-PP	O
120	120	CD	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
6/6/07	6/6/07	CD	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
began	begin	VBD	B-VP	O
hypotensive	hypotensive	JJ	B-ADJP	O
with	with	IN	B-PP	O
systolics	systolic	NNS	B-NP	O
of	of	IN	B-PP	O
70	70	CD	B-NP	O
.	.	.	O	O

Cardiology	Cardiology	NN	B-NP	O
was	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	I-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
Lopressor	Lopressor	NN	B-NP	O
and	and	CC	I-NP	O
diltiazem	diltiazem	NN	I-NP	O
drip	drip	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
remained	remain	VBD	B-VP	O
hypotensive	hypotensive	JJ	B-ADJP	O
despite	despite	IN	B-PP	O
IV	IV	CD	B-NP	O
boluses	bolus	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
switched	switch	VBN	I-VP	O
to	to	TO	B-PP	O
amiodarone	amiodarone	NN	B-NP	O
mode	mode	NN	I-NP	O
and	and	CC	I-NP	O
drip	drip	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
again	again	RB	B-ADVP	O
he	he	PRP	B-NP	O
became	become	VBD	B-VP	O
hypotensive	hypotensive	JJ	B-ADJP	O
.	.	.	O	O

Therefore	Therefore	RB	B-ADVP	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
unit	unit	NN	I-NP	O
and	and	CC	O	O
given	give	VBN	B-VP	O
a	a	DT	B-NP	O
digoxin	digoxin	NN	I-NP	O
load	load	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
possible	possible	JJ	I-NP	O
electrocardioversion	electrocardioversion	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
remained	remain	VBD	B-VP	O
asymptomatic	asymptomatic	JJ	B-ADJP	O
throughout	throughout	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
with	with	IN	B-PP	O
low	low	JJ	B-NP	O
blood	blood	NN	I-NP	O
pressures	pressure	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
ICU	ICU	NN	I-NP	B-DNA
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
again	again	RB	I-VP	O
started	start	VBN	I-VP	O
and	and	CC	I-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
amiodarone	amiodarone	NN	B-NP	O
IV	IV	CD	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
tolerated	tolerate	VBD	B-VP	O
it	it	PRP	B-NP	O
without	without	IN	B-PP	O
a	a	DT	B-NP	O
problem	problem	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
did	do	VBD	B-VP	O
have	have	VB	I-VP	O
an	an	DT	B-NP	O
episode	episode	NN	I-NP	O
of	of	IN	B-PP	O
bright	bright	JJ	B-NP	O
red	red	JJ	I-NP	O
blood	blood	NN	I-NP	O
from	from	IN	B-PP	O
his	his	PRP$	B-NP	O
NG	NG	NN	I-NP	O
tube	tube	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
ICU	ICU	NN	I-NP	B-DNA
and	and	CC	I-NP	O
GI	GI	NN	I-NP	O
was	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
.	.	.	O	O

They	They	PRP	B-NP	O
felt	feel	VBD	B-VP	O
given	give	VBN	B-PP	O
that	that	IN	B-SBAR	O
his	his	PRP$	B-NP	O
hematocrits	hematocrit	NNS	I-NP	O
have	have	VBP	B-VP	O
stabilized	stabilize	VBN	I-VP	O
after	after	IN	B-PP	O
two	two	CD	B-NP	O
units	unit	NNS	I-NP	O
of	of	IN	B-PP	O
packed	packed	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
,	,	,	O	O
he	he	PRP	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
need	need	VB	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
urgently	urgently	RB	I-VP	O
scoped	scope	VBN	I-VP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
Pepcid	Pepcid	NN	B-NP	B-protein
IV	IV	CD	I-NP	I-protein
and	and	CC	O	O
a	a	DT	B-NP	O
Nexium	Nexium	NN	I-NP	O
drip	drip	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
had	have	VBD	B-VP	O
hematocrit	hematocrit	NN	B-NP	O
measured	measure	VBN	B-VP	O
q.	q.	NN	B-NP	O
6	6	CD	I-NP	O
h.	h.	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
remains	remain	VBZ	B-VP	O
normal	normal	JJ	B-ADJP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
back	back	RB	B-ADVP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
floor	floor	NN	I-NP	O
on	on	IN	B-PP	O
these	these	DT	B-NP	O
medications	medication	NNS	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
TPN	TPN	NN	B-NP	B-protein
after	after	IN	B-PP	O
a	a	DT	B-NP	O
PICC	PICC	NN	I-NP	B-cell_line
line	line	NN	I-NP	I-cell_line
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
and	and	CC	O	O
continued	continue	VBN	B-VP	O
to	to	TO	I-VP	O
do	do	VB	I-VP	O
well	well	RB	B-ADVP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
scoped	scope	VBN	I-VP	O
by	by	IN	B-PP	O
GI	GI	NN	B-NP	O
on	on	IN	B-PP	O
3/24/07	3/24/07	CD	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
diffuse	diffuse	JJ	B-NP	O
gastritis	gastritis	NN	I-NP	O
thought	think	VBN	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
NG	NG	NN	I-NP	O
tube	tube	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
two	two	CD	B-NP	O
ulcers	ulcer	NNS	I-NP	O
turned	turn	VBD	B-VP	O
out	out	RP	B-PRT	O
bleeding	bleeding	NN	B-NP	O
.	.	.	O	O

Postprocedure	Postprocedure	NNP	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
Carafate	Carafate	NNP	B-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	B-PP	O
Nexium	Nexium	NNP	B-NP	O
p.o.	p.o.	FW	I-NP	O
after	after	IN	B-SBAR	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
taking	take	VBG	I-VP	O
a	a	DT	B-NP	O
diet	diet	NN	I-NP	O
.	.	.	O	O

Again	Again	RB	B-ADVP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
PICC	PICC	NN	I-NP	B-cell_line
line	line	NN	I-NP	I-cell_line
was	be	VBD	B-VP	O
safe	safe	JJ	B-ADJP	O
on	on	IN	B-PP	O
4/15/07	4/15/07	CD	B-NP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
TPN	TPN	NN	B-NP	B-protein
on	on	IN	B-PP	O
9/25/07	9/25/07	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
NG	NG	NN	I-NP	O
tube	tube	NN	I-NP	O
was	be	VBD	B-VP	O
removed	remove	VBN	I-VP	O
on	on	IN	B-PP	O
3/24/07	3/24/07	CD	B-NP	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
diet	diet	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
slowly	slowly	RB	I-VP	O
advanced	advance	VBN	I-VP	O
.	.	.	O	O

He	He	PRP	B-NP	O
is	be	VBZ	B-VP	O
being	be	VBG	I-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
TPN	TPN	NN	B-NP	B-protein
as	as	IN	B-PP	O
his	his	PRP$	B-NP	O
total	total	JJ	I-NP	O
caloric	caloric	JJ	I-NP	O
needs	need	NNS	I-NP	O
are	be	VBP	B-VP	O
still	still	RB	I-VP	O
not	not	RB	I-VP	O
being	be	VBG	I-VP	O
met	meet	VBN	I-VP	O
by	by	IN	B-PP	O
p.o.	p.o.	NN	B-NP	O
nutrition	nutrition	NN	I-NP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
is	be	VBZ	B-VP	O
in	in	IN	B-PP	O
good	good	JJ	B-NP	O
condition	condition	NN	I-NP	O
on	on	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
not	not	RB	O	O
anti-coagulated	anti-coagulated	JJ	B-ADJP	O
for	for	IN	B-PP	O
his	his	PRP$	B-NP	O
Atrial	Atrial	JJ	I-NP	O
Fibrillation	Fibrillation	NN	I-NP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
risk	risk	NN	I-NP	O
of	of	IN	B-PP	O
GI	GI	NN	B-NP	O
bleeding	bleeding	NN	I-NP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
decided	decide	VBN	B-VP	O
by	by	IN	B-PP	O
GI	GI	NN	B-NP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
0-8655717	0-8655717	CD	B-NP	O
CSSten	CSSten	NNP	I-NP	O
Tel	Tel	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
VOCK	VOCK	NNP	B-NP	O
,	,	,	O	O
RODOLFO	RODOLFO	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
REGINALDO	REGINALDO	NNP	B-NP	O
,	,	,	O	O
EARLE	EARLE	NNP	B-NP	O
CHANCE	CHANCE	NNP	I-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
2930893	2930893	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
4/2/07	4/2/07	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
4/2/07	4/2/07	CD	B-NP	O

